News & Perspective

Aug 16, 2018

Aug 16, 2018
Aedes aegypti closeup

Study profiles local Zika threat to California; first live attenuated vaccine trial begins

In another new development, the NIH today announced the start of the first human trial of a live attenuated vaccine against Zika.

Aug 16, 2018
vaccine research

CEPI announces new collaboration and funding for Lassa vaccine

The announcement comes as Nigeria is experiencing its largest outbreak, with 481 confirmed cases reported as of last week, 133 of them fatal.

Aug 14, 2018

Aug 14, 2018
IV therapy

DRC Ebola cases surpass earlier outbreak total, virus infects 4 more health workers

The WHO's director-general today warned that 'red zones' in conflict areas could be hiding places for Ebola.

Aug 13, 2018

Aug 13, 2018
Ebola treatment unit

Worries about security and healthcare exposures as DRC Ebola total grows to 52

A WHO official said Ebola spread could get worse before it gets better, due to health worker exposures early in the outbreak.

Jul 25, 2018

Jul 25, 2018
Bacteria in bloodstream

NIH experts note risks of 'difficult-to-treat' bloodstream infections

Among 440 patients with difficult-to-treat multidrug-resistant infections, 43% died.

Apr 25, 2018

Apr 25, 2018
Malaria mosquito net

Malaria studies show benefit of mass treatment, methylene blue

On World Malaria Day, global health leaders aired concerns about stalled progress in some regions and recommitted to the battle against the disease.

Feb 19, 2018

Feb 19, 2018
Drawing vaccine from a vial

Senate bill would jump-start universal flu vaccine efforts

The proposed law would direct $200 million a year for 5 years to research.

Dec 19, 2017

Dec 19, 2017
Ebola virus

Feds lift gain-of-function research pause, offer guidance

Researchers are relieved to resume experiments, but some public health questions remain.

Oct 19, 2017

Oct 19, 2017
Ferret

Study details pandemic potential of latest H7N9 flu strains

In a sample from a patient who died, researchers saw signs that the H7N9 virus had started to mutate to a form resistant to Tamiflu.

Oct 11, 2017

Oct 11, 2017
Ebola vaccine study

Liberia trial finds Ebola vaccines yield year-long immune response

A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»